StockData
Vir Biotechnology, Inc. logo

Vir Biotechnology, Inc. (VIR) stock

VIRNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 11/3030% below fair value
$9.25−0.33 (-3.44%)

Close on Nov 17, 2026Market cap $1.57BP/E –Yield –

Vir Biotechnology market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Vir Biotechnology's market cap was $2.22B on Nov 11, 2026, against $892.53M a year earlier. Over the last 5 years it ranged from $682.03M to $5.48B, with a median of $1.42B.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$2.22B+165.0%
2025Dec 31, 2025$838.31M-16.5%
2024Dec 31, 2024$1.00B-25.8%
2023Dec 29, 2023$1.35B-59.8%
2022Dec 30, 2022$3.37B-38.5%
2021Dec 31, 2021$5.48B+61.1%
2020Dec 31, 2020$3.40B+2205.9%
2019Dec 31, 2019$147.48M–

More Vir Biotechnology figures

See a number that looks wrong?